 | • レポートコード：20QY06-05451 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、口内乾燥症（ドライマウス）治療のグローバル市場について種類別（唾液刺激剤、唾液代用品、歯磨剤）、用途別（OTC、処方箋）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・口内乾燥症（ドライマウス）治療市場の概要 ・世界の主要地域別口内乾燥症（ドライマウス）治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の口内乾燥症（ドライマウス）治療市場規模2015-2026：種類別（唾液刺激剤、唾液代用品、歯磨剤） ・世界の口内乾燥症（ドライマウス）治療市場規模2015-2026：用途別（OTC、処方箋） ・口内乾燥症（ドライマウス）治療の北米市場規模2015-2020 ・口内乾燥症（ドライマウス）治療のヨーロッパ市場規模2015-2020 ・口内乾燥症（ドライマウス）治療の中国市場規模2015-2020 ・口内乾燥症（ドライマウス）治療の日本市場規模2015-2020 ・口内乾燥症（ドライマウス）治療の東南アジア市場規模2015-2020 ・口内乾燥症（ドライマウス）治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GlaxoSmithKline plc、Church & Dwight, Inc.、Colgate-Palmolive Company、Hikma Pharmaceuticals PLC、Pendopharm、Sun Pharmaceuticals Industries Ltd.、Lupin Pharmaceuticals, Inc.、Pfizer, Inc.、Parnell Pharmaceuticals, Inc.、Acacia Pharma、OraCoat） ・口内乾燥症（ドライマウス）治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口内乾燥症（ドライマウス）治療の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Xerostomia (Dry Mouth) Therapeutics Market
The global Xerostomia (Dry Mouth) Therapeutics market was valued at US$ 556.9 million in 2019 and will reach US$ 657.9 million by the end of 2026, growing at a CAGR of 2.4% during 2020-2026.
Global Xerostomia (Dry Mouth) Therapeutics Scope and Market Size
The global Xerostomia (Dry Mouth) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Xerostomia (Dry Mouth) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Xerostomia (Dry Mouth) Therapeutics market is segmented into
Salivary Stimulants
Salivary Substitutes
Dentifrices
Segment by Application, the Xerostomia (Dry Mouth) Therapeutics market is segmented into
OTC
Prescription
The Xerostomia (Dry Mouth) Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Xerostomia (Dry Mouth) Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Xerostomia (Dry Mouth) Therapeutics Market Share Analysis
Xerostomia (Dry Mouth) Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Xerostomia (Dry Mouth) Therapeutics business, the date to enter into the Xerostomia (Dry Mouth) Therapeutics market, Xerostomia (Dry Mouth) Therapeutics product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Table of Contents
1 Xerostomia (Dry Mouth) Therapeutics Market Overview
1.1 Xerostomia (Dry Mouth) Therapeutics Product Scope
1.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type
1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2020-2026)
1.2.2 Salivary Stimulants
1.2.3 Salivary Substitutes
1.2.4 Dentifrices
1.3 Xerostomia (Dry Mouth) Therapeutics Segment by Application
1.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 OTC
1.3.3 Prescription
1.4 Xerostomia (Dry Mouth) Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Xerostomia (Dry Mouth) Therapeutics Price Trends (2015-2026)
2 Xerostomia (Dry Mouth) Therapeutics Estimate and Forecast by Region
2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Xerostomia (Dry Mouth) Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Xerostomia (Dry Mouth) Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Xerostomia (Dry Mouth) Therapeutics Estimates and Projections (2015-2026)
3 Global Xerostomia (Dry Mouth) Therapeutics Competition Landscape by Players
3.1 Global Top Xerostomia (Dry Mouth) Therapeutics Players by Sales (2015-2020)
3.2 Global Top Xerostomia (Dry Mouth) Therapeutics Players by Revenue (2015-2020)
3.3 Global Xerostomia (Dry Mouth) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth) Therapeutics as of 2019)
3.4 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Xerostomia (Dry Mouth) Therapeutics Players (Opinion Leaders)
4 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Type
4.1 Global Xerostomia (Dry Mouth) Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2014-2020)
4.2 Global Xerostomia (Dry Mouth) Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2021-2026)
5 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Application
5.1 Global Xerostomia (Dry Mouth) Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2015-2020)
5.2 Global Xerostomia (Dry Mouth) Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Application (2021-2026)
3 North America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
3.2 North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
3.3 North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
3.4 North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
4 Europe Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
4.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
4.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
4.4 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
5 China Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
5.2 China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
5.3 China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
5.4 China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
6 Japan Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
6.2 Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
6.3 Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
6.4 Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
7 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
7.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
8 India Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures
8.2 India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
8.3 India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
8.4 India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Xerostomia (Dry Mouth) Therapeutics Business
12.1 GlaxoSmithKline plc
12.1.1 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.1.2 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Products Offered
12.1.5 GlaxoSmithKline plc Recent Development
12.2 Church & Dwight, Inc.
12.2.1 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.2.2 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
12.2.5 Church & Dwight, Inc. Recent Development
12.3 Colgate-Palmolive Company
12.3.1 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.3.2 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Products Offered
12.3.5 Colgate-Palmolive Company Recent Development
12.4 Hikma Pharmaceuticals PLC
12.4.1 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.4.2 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Products Offered
12.4.5 Hikma Pharmaceuticals PLC Recent Development
12.5 Pendopharm
12.5.1 Pendopharm Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.5.2 Pendopharm Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Products Offered
12.5.5 Pendopharm Recent Development
12.6 Sun Pharmaceuticals Industries Ltd.
12.6.1 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.6.2 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Products Offered
12.6.5 Sun Pharmaceuticals Industries Ltd. Recent Development
12.7 Lupin Pharmaceuticals, Inc.
12.7.1 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.7.2 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
12.7.5 Lupin Pharmaceuticals, Inc. Recent Development
12.8 Pfizer, Inc.
12.8.1 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.8.2 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
12.8.5 Pfizer, Inc. Recent Development
12.9 Parnell Pharmaceuticals, Inc.
12.9.1 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.9.2 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
12.9.5 Parnell Pharmaceuticals, Inc. Recent Development
12.10 Acacia Pharma
12.10.1 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.10.2 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Products Offered
12.10.5 Acacia Pharma Recent Development
12.11 OraCoat
12.11.1 OraCoat Xerostomia (Dry Mouth) Therapeutics Corporation Information
12.11.2 OraCoat Xerostomia (Dry Mouth) Therapeutics Business Overview and Total Revenue
12.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 OraCoat Xerostomia (Dry Mouth) Therapeutics Products Offered
12.11.5 OraCoat Recent Development
13 Xerostomia (Dry Mouth) Therapeutics Manufacturing Cost Analysis
13.1 Xerostomia (Dry Mouth) Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics
13.4 Xerostomia (Dry Mouth) Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Xerostomia (Dry Mouth) Therapeutics Distributors List
14.3 Xerostomia (Dry Mouth) Therapeutics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Xerostomia (Dry Mouth) Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Region (2015-2020)
Table 5. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2015-2020)
Table 6. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Region (2015-2020)
Table 8. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Xerostomia (Dry Mouth) Therapeutics (K MT) of Key Companies (2015-2020)
Table 13. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Company (2015-2020)
Table 14. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Company (2015-2020)
Table 16. Global Xerostomia (Dry Mouth) Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth) Therapeutics as of 2019)
Table 17. Global Xerostomia (Dry Mouth) Therapeutics Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Sites and Area Served
Table 19. Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Xerostomia (Dry Mouth) Therapeutics Players
Table 22. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 23. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Xerostomia (Dry Mouth) Therapeutics Price (K MT) by Type (2015-2020)
Table 26. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2026)
Table 27. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2026)
Table 29. Global Xerostomia (Dry Mouth) Therapeutics Price (K MT) by Type (2021-2026)
Table 30. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 31. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2015-2020)
Table 32. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Xerostomia (Dry Mouth) Therapeutics Price (K MT) by Application (2015-2020)
Table 34. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2021-2026)
Table 35. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2026)
Table 36. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2026)
Table 38. Global Xerostomia (Dry Mouth) Therapeutics Price (K MT) by Application (2021-2026)
Table 39. United States Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 40. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 41. United States Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 42. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 43. United States Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 44. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Europe Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 46. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 47. Europe Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 48. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 49. Europe Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 50. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 51. China Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 52. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 53. China Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 54. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 55. China Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 56. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Japan Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 58. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 59. Japan Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 60. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Japan Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 62. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
Table 69. India Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Company (2015-2020)
Table 70. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2015-2020)
Table 71. India Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Type (2015-2020)
Table 72. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
Table 73. India Xerostomia (Dry Mouth) Therapeutics Sales (K MT) by Application (2015-2020)
Table 74. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline plc Corporation Information
Table 76. GlaxoSmithKline plc Description and Business Overview
Table 77. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product
Table 79. GlaxoSmithKline plc Recent Development
Table 80. Church & Dwight, Inc. Corporation Information
Table 81. Church & Dwight, Inc. Description and Business Overview
Table 82. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product
Table 84. Church & Dwight, Inc. Recent Development
Table 85. Colgate-Palmolive Company Corporation Information
Table 86. Colgate-Palmolive Company Description and Business Overview
Table 87. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product
Table 89. Colgate-Palmolive Company Recent Development
Table 90. Hikma Pharmaceuticals PLC Corporation Information
Table 91. Hikma Pharmaceuticals PLC Description and Business Overview
Table 92. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product
Table 94. Hikma Pharmaceuticals PLC Recent Development
Table 95. Pendopharm Corporation Information
Table 96. Pendopharm Description and Business Overview
Table 97. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pendopharm Xerostomia (Dry Mouth) Therapeutics Product
Table 99. Pendopharm Recent Development
Table 100. Sun Pharmaceuticals Industries Ltd. Corporation Information
Table 101. Sun Pharmaceuticals Industries Ltd. Description and Business Overview
Table 102. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product
Table 104. Sun Pharmaceuticals Industries Ltd. Recent Development
Table 105. Lupin Pharmaceuticals, Inc. Corporation Information
Table 106. Lupin Pharmaceuticals, Inc. Description and Business Overview
Table 107. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product
Table 109. Lupin Pharmaceuticals, Inc. Recent Development
Table 110. Pfizer, Inc. Corporation Information
Table 111. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer, Inc. Description and Business Overview
Table 113. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product
Table 114. Pfizer, Inc. Recent Development
Table 115. Parnell Pharmaceuticals, Inc. Corporation Information
Table 116. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Parnell Pharmaceuticals, Inc. Description and Business Overview
Table 118. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product
Table 119. Parnell Pharmaceuticals, Inc. Recent Development
Table 120. Acacia Pharma Corporation Information
Table 121. Acacia Pharma Description and Business Overview
Table 122. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product
Table 124. Acacia Pharma Recent Development
Table 125. OraCoat Corporation Information
Table 126. OraCoat Description and Business Overview
Table 127. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. OraCoat Xerostomia (Dry Mouth) Therapeutics Product
Table 129. OraCoat Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Xerostomia (Dry Mouth) Therapeutics Distributors List
Table 133. Xerostomia (Dry Mouth) Therapeutics Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Xerostomia (Dry Mouth) Therapeutics Product Picture
Figure 2. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Xerostomia (Dry Mouth) Therapeutics Market Share by Application in 2020 & 2026
Figure 6. OTC Examples
Figure 7. Prescription Examples
Figure 8. Global Xerostomia (Dry Mouth) Therapeutics Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Xerostomia (Dry Mouth) Therapeutics Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Xerostomia (Dry Mouth) Therapeutics Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Xerostomia (Dry Mouth) Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Xerostomia (Dry Mouth) Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Xerostomia (Dry Mouth) Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Xerostomia (Dry Mouth) Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Xerostomia (Dry Mouth) Therapeutics Players Market Share by Revenue in Xerostomia (Dry Mouth) Therapeutics 2015 & 2019
Figure 26. Xerostomia (Dry Mouth) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2015-2020)
Figure 28. Global Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2015-2020)
Figure 30. Global Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 32. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 33. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 34. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 35. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application in 2019
Figure 36. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 37. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 38. China Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application in 2019
Figure 39. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 40. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 41. Japan Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application in 2019
Figure 42. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 43. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 44. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application in 2019
Figure 45. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 46. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2019
Figure 47. India Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application in 2019
Figure 48. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Church & Dwight, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Colgate-Palmolive Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Hikma Pharmaceuticals PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pendopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sun Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Lupin Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Parnell Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Acacia Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. OraCoat Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Xerostomia (Dry Mouth) Therapeutics
Figure 61. Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics
Figure 62. Xerostomia (Dry Mouth) Therapeutics Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
睡眠時無呼吸用口装着型機器の世界市場レポート2020 A recently published report by QY Research titled Global Mouth Devices for Sleep Apnea Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…- 口内潰瘍治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Mouth Ulcer Treatment Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …
- 口蹄疫（FMD）ワクチンの世界市場レポート2020 Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. The classificati…
- 口解剖モデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mouth Anatomical Model market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mouth Anatomical Model…
- 口蹄疫（FMD）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Foot and Mouth Disease (FMD) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1280.5 million by 2025, from USD 900.9 million in 2019. The …